Search research articles
Contact Us
Filters
Showing results (51-60 of 110) with videos related to
Page
of 11
Sort By:
Neuroimage. Clinical
|
November 2, 2013
Disturbed resting state EEG synchronization in bipolar disorder: A graph-theoretic analysis
Dae-Jin Kim, Amanda R Bolbecker, Josselyn Howell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 3, 2002
Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo
Igor Elman, David S Goldstein, Alan I Green, et al.
Psychopharmacology
|
September 19, 2016
Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats
Kalyan N Rao, Alena M Sentir, Eric A Engleman, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 23, 2017
Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder
Ashley M Schnakenberg Martin, Lisa Bartolomeo, Josselyn Howell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 2, 2004
Amantadine for weight gain associated with olanzapine treatment
Walter Deberdt, Andrew Winokur, Patrizia A Cavazzoni, et al.
Lancet (London, England)
|
December 17, 2023
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
Inder Kaul, Sharon Sawchak, Christoph U Correll, et al.
The Journal of Clinical Psychiatry
|
November 25, 2003
Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years
Peter D Feldman, Christopher J Kaiser, John S Kennedy, et al.
Schizophrenia Research
|
January 31, 2012
Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder
Olga Rass, Jennifer K Forsyth, Giri P Krishnan, et al.
Schizophrenia Research
|
July 13, 2004
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder
Vivian Mitropoulou, Marianne Goodman, Serge Sevy, et al.
Schizophrenia Research
|
November 8, 2017
Metacognitive Reflection and Insight Therapy for Early Psychosis: A preliminary study of a novel integrative psychotherapy
Jenifer L Vohs, Bethany L Leonhardt, Alison V James, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 110) with videos related to
Sort By:
Page
of 11
Neuroimage. Clinical
|
November 2, 2013
Disturbed resting state EEG synchronization in bipolar disorder: A graph-theoretic analysis
Dae-Jin Kim, Amanda R Bolbecker, Josselyn Howell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 3, 2002
Effects of risperidone on the peripheral noradrenegic system in patients with schizophrenia: a comparison with clozapine and placebo
Igor Elman, David S Goldstein, Alan I Green, et al.
Psychopharmacology
|
September 19, 2016
Toward early estimation and treatment of addiction vulnerability: radial arm maze and N-acetyl cysteine before cocaine sensitization or nicotine self-administration in neonatal ventral hippocampal lesion rats
Kalyan N Rao, Alena M Sentir, Eric A Engleman, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 23, 2017
Auditory feature perception and auditory hallucinatory experiences in schizophrenia spectrum disorder
Ashley M Schnakenberg Martin, Lisa Bartolomeo, Josselyn Howell, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
December 2, 2004
Amantadine for weight gain associated with olanzapine treatment
Walter Deberdt, Andrew Winokur, Patrizia A Cavazzoni, et al.
Lancet (London, England)
|
December 17, 2023
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
Inder Kaul, Sharon Sawchak, Christoph U Correll, et al.
The Journal of Clinical Psychiatry
|
November 25, 2003
Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years
Peter D Feldman, Christopher J Kaiser, John S Kennedy, et al.
Schizophrenia Research
|
January 31, 2012
Auditory steady state response in the schizophrenia, first-degree relatives, and schizotypal personality disorder
Olga Rass, Jennifer K Forsyth, Giri P Krishnan, et al.
Schizophrenia Research
|
July 13, 2004
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder
Vivian Mitropoulou, Marianne Goodman, Serge Sevy, et al.
Schizophrenia Research
|
November 8, 2017
Metacognitive Reflection and Insight Therapy for Early Psychosis: A preliminary study of a novel integrative psychotherapy
Jenifer L Vohs, Bethany L Leonhardt, Alison V James, et al.
Page
of 11